ANI Pharmaceuticals, Inc. (ANIP)
Market: NASD |
Currency: USD
Address: 210 Main Street West
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
📈 ANI Pharmaceuticals, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$82.63
-
Upside/Downside from Analyst Target:
27.78%
-
Broker Call:
13
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
25-50%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for ANI Pharmaceuticals, Inc.
Date | Reported EPS |
---|
2026-02-26 (estimated upcoming) | - |
2025-11-06 (estimated upcoming) | - |
2025-08-04 (estimated upcoming) | - |
2025-05-08 | - |
2025-02-28 | 1.63 |
2025-01-13 | - |
2024-11-08 | 1.34 |
2024-08-06 | 1.02 |
2024-05-10 | 1.21 |
2024-02-29 | 1 |
2023-11-08 | 1.27 |
2023-08-09 | 1.28 |
2023-05-08 | 1.17 |
2023-03-09 | 0.76 |
2022-11-09 | 0.64 |
2022-08-08 | 0.13 |
2022-05-10 | -0.12 |
2022-03-15 | 0.54 |
2021-11-01 | 1.01 |
2021-08-06 | 0.67 |
2021-05-07 | 1.04 |
2021-03-09 | 0.8 |
2020-11-05 | 0.97 |
2020-08-06 | 0.69 |
2020-05-07 | 1.04 |
📰 Related News & Research
No related articles found for "ani pharmaceuticals".